We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life.
- Authors
Alvarez-Cuesta, E; Aragoneses-Gilsanz, E; Martín-Garcia, C; Berges-Gimeno, P; Gonzalez-Mancebo, E; Cuesta-Herranz, J
- Abstract
Immunotherapy (IT) with modified allergens reduces allergic rhinitis (AR) symptoms and medications requirements. Improvement of quality of life (QOL) is a key point in the treatment of AR. The aim of this study was to provide evidence of changes related to the patient's QOL (well-being) induced by a modified (depigmented glutaraldehyde-polymerized) therapeutic vaccine and of its safety.
- Publication
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2005, Vol 35, Issue 5, p572
- ISSN
0954-7894
- Publication type
Journal Article
- DOI
10.1111/j.1365-2222.2005.02245.x